As shown by numerous studies, obesity contributes to development of serious diseases, such as type 2 diabetes (non-insulin-dependent diabetes).

This disease is caused by the body’s inability to use glucose, which is the main source of energy in the body. It was found that more than 80% of patients with type 2 diabetes are overweight.

Weight loss and increase of physical activity are the most important steps towards achieving of optimal glycemic control.

Metermine is one of approved medications in Australia used for treatment of obesity and overweight in adults and adolescents.

Studies have shown that even in relatively short-term use of Metermine in obese patient, the drug significantly reduces weight that contributes to:

  • Improvement of glucose metabolism
  • Decrease in insulin resistance
  • Normalization of carbohydrate and lipid metabolism

If you are taking an oral antidiabetic drug and Metermine was prescribed for overweight treatment, take caution because these drugs can interact with each other.

Clinical studies have shown that Metermine can potentiate hypoglycemic action of insulin and other oral hypoglycemics that may cause a decrease in blood glucose concentration.

When using Metermine and changing diet, the body’s need for insulin or other antidiabetic agent may vary.

Low blood sugar level (or hypoglycemia) may lead to serious health complications in the person with diabetes.

  • Therefore, while using Metermine together with insulin, sulfonylureas (especially glyburide), meglitinides and thiazolidinediones, it is very important to regularly control glucose levels.

All experts agree that regardless of age and gender, Metermine effectively reduces overweight. This helps to restore cells sensitivity to insulin and to normalize blood sugar level.